Patents by Inventor John D. Brotherton

John D. Brotherton has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Metabolic detoxification system and method
    Patent number: 8608953
    Abstract: An extracorporeal filtration and detoxification system and method generally comprise separating ultrafiltrate from cellular components of blood, treating the ultrafiltrate independently of the cellular components in a recirculation circuit, recombining treated ultrafiltrate and the cellular components, and returning whole blood to the patient. A recirculation circuit generally comprises an active cartridge including active cells operative to effectuate a selected treatment; in some embodiments, the active cells are the C3A cell line.
    Type: Grant
    Filed: January 30, 2012
    Date of Patent: December 17, 2013
    Assignee: Vital Therapies, Inc.
    Inventors: John D. Brotherton, Dar He
  • Metabolic Detoxification System and Method
    Publication number: 20120197174
    Abstract: An extracorporeal filtration and detoxification system and method generally comprise separating ultrafiltrate from cellular components of blood, treating the ultrafiltrate independently of the cellular components in a recirculation circuit, recombining treated ultrafiltrate and the cellular components, and returning whole blood to the patient. A recirculation circuit generally comprises an active cartridge including active cells operative to effectuate a selected treatment; in some embodiments, the active cells are the C3A cell line.
    Type: Application
    Filed: January 30, 2012
    Publication date: August 2, 2012
    Inventors: John D. Brotherton, Dar He
  • Metabolic detoxification and method
    Patent number: 8105491
    Abstract: An extracorporeal filtration and detoxification system and method generally comprise separating ultrafiltrate from cellular components of blood, treating the ultrafiltrate independently of the cellular components in a recirculation circuit, recombining treated ultrafiltrate and the cellular components, and returning whole blood to the patient. A recirculation circuit generally comprises an active cartridge including active cells operative to effectuate a selected treatment; in some embodiments, the active cells are the C3A cell line.
    Type: Grant
    Filed: February 23, 2005
    Date of Patent: January 31, 2012
    Assignee: Vital Therapies, Inc.
    Inventors: John D. Brotherton, Dar He